Jelmyto

UroGen presses ahead with RTGel after Botox pairing stumbles in overactive bladder trial
Fierce Pharma
Thu, 09/3/20 - 11:52 pm
Urogen
AbbVie
Jelmyto
overactive bladder
UroGen Gets FDA Nod for Low-Grade Upper Tract Urothelial Cancer Drug
Xconomy
Wed, 04/15/20 - 11:27 pm
Urogen
urothelial cancer
FDA
Jelmyto